R Edens to Humans
This is a "connection" page, showing publications R Edens has written about Humans.
Connection Strength
0.245
-
Less Is More in Post Pediatric Heart Transplant Care. Ann Thorac Surg. 2019 01; 107(1):165-171.
Score: 0.035
-
Development of a Pediatric Cardiac Mechanical Support Program. Artif Organs. 2018 Apr; 42(4):444-451.
Score: 0.033
-
Fibrosis in Fontan physiology. J Thorac Cardiovasc Surg. 2016 06; 151(6):1527-8.
Score: 0.030
-
Outcomes of Pneumocystis jiroveci pneumonia infections in pediatric heart transplant recipients. Pediatr Transplant. 2011 Dec; 15(8):844-8.
Score: 0.022
-
Takotsubo-like cardiomyopathy in a 17-year-old male with a pheochromocytoma. Pediatr Cardiol. 2009 Feb; 30(2):184-7.
Score: 0.018
-
The Effect of Infectious Complications During Ventricular Assist Device Use on Outcomes of Pediatric Heart Transplantation. ASAIO J. 2022 02 01; 68(2):287-296.
Score: 0.011
-
Certain high molecular weight heparin chains have high affinity for vitronectin. Arch Biochem Biophys. 2001 Jul 15; 391(2):278-85.
Score: 0.011
-
Resource utilization in children with paracorporeal continuous-flow ventricular assist devices. J Heart Lung Transplant. 2021 06; 40(6):478-487.
Score: 0.011
-
Resource Utilization in Pediatric Patients Supported With Ventricular Assist Devices in the United States: A Multicenter Study From the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support and the Pediatric Health Information System. J Am Heart Assoc. 2018 06 01; 7(11).
Score: 0.009
-
Fontan Patient Survival After Pediatric Heart Transplantation Has Improved in the Current Era. Ann Thorac Surg. 2017 Apr; 103(4):1315-1320.
Score: 0.008
-
Use of HeartWare Ventricular Assist System for systemic ventricular support of a pediatric patient after Mustard procedure. World J Pediatr Congenit Heart Surg. 2015 Apr; 6(2):339-41.
Score: 0.007
-
Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacology. 1994 Mar-Apr; 27(2):145-53.
Score: 0.006
-
Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy. Circulation. 2012 Aug 28; 126(9):1079-86.
Score: 0.006
-
Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant. 2012 Feb; 31(2):133-9.
Score: 0.006
-
Allosensitization and outcomes in pediatric heart transplantation. J Heart Lung Transplant. 2011 Nov; 30(11):1221-7.
Score: 0.005
-
Outcomes after listing for primary transplantation for infants with unoperated-on non-hypoplastic left heart syndrome congenital heart disease: a multi-institutional study. J Heart Lung Transplant. 2011 Sep; 30(9):1023-32.
Score: 0.005
-
Orthotopic heart transplantation in a child with hereditary spherocytosis. Artif Organs. 2010 Dec; 34(12):1154-6.
Score: 0.005
-
Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch. J Heart Lung Transplant. 2007 Nov; 26(11):1163-9.
Score: 0.004
-
Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta. 2005 Nov 15; 1726(2):168-76.
Score: 0.004
-
Poly(ethylene glycol)-based biosensor chip to study heparin-protein interactions. Anal Biochem. 2005 Aug 01; 343(1):176-8.
Score: 0.004
-
Balloon aortic valvuloplasty in a 1,600-gram infant. Catheter Cardiovasc Interv. 2000 Jul; 50(3):322-5.
Score: 0.003
-
Eosinophil granule cationic proteins regulate the classical pathway of complement. Immunology. 1995 Feb; 84(2):213-9.
Score: 0.002
-
Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway. J Immunol. 1992 Jul 15; 149(2):643-8.
Score: 0.001